CONCLUSION: Administering higher doses on a 3-weekly schedule did not compromise the efficacy and safety of trastuzumab in women with HER2-positive MBC, and
trastuzumab A drug used alone or with other drugs to treat certain types of breast cancer, stomach cancer, and gastroesophageal junction cancer that are HER2 Trastuzumab has also been shown to penetrate an impaired blood–brain barrier to a limited degree, such as during radiotherapy, and intrathecal delivery of
sap ย่อ มา จาก แนวทางการกากับการใช้ยา Trastuzumab ข้อบ่งใช้มะเร็งเต้านมระยะเริ่มต้น ผู้ป่วยสิทธิประกันสุขภาพถ้วนหน้า Page 2 Page 3 Page 4 CONCLUSION: Administering higher doses on a 3-weekly schedule did not compromise the efficacy and safety of trastuzumab in women with HER2-positive MBC, and
